TY  - JOUR
AU  - Cortes, Marta
AU  - Carceller, Fernando
AU  - Rubio-San-Simon, Alba
AU  - Vaidya, Sucheta J
AU  - Bautista, Francisco
AU  - Moreno, Lucas
PY  - 2021
DO  - 10.1002/pbc.29551
UR  - http://hdl.handle.net/10668/22439
T2  - Pediatric blood & cancer
AB  - Neuroblastoma is the most common extracranial tumour in children, and prognosis for refractory and relapsed disease is still poor. Early-phase clinical trials play a pivotal role in the development of novel drugs. Ensuring adequate recruitment is...
LA  - en
PB  - Wiley Periodicals 
KW  - Phase I trial
KW  - Phase II trial
KW  - Access to innovation
KW  - Clinical trial
KW  - Drug development
KW  - Relapsed neuroblastoma
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - Child
KW  - Drug Administration Schedule
KW  - Humans
KW  - Neoplasm Recurrence, Local
KW  - Neuroblastoma
KW  - Prognosis
TI  - Access to early-phase clinical trials for children with relapsed and refractory neuroblastoma: A multicentre international study.
TY  - research article
VL  - 69
ER  -